Founder
OPTIC
The startup develops AI technology that accelerates molecular discovery by utilizing machine learning algorithms to analyze molecular activity for precise identification of potential drug compounds. This approach enhances the efficiency of drug compound discovery and simplifies virtual screening benchmarks for pharmaceutical companies.
- Artificial Intelligence
- Data & Analytics
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$30.2MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
across 2 rounds
$11M · Seed
Announced Dec 2024
Disclosed cumulative: $11M
Not on chart (date unknown): Series A $19.2M
RoundDateAmountValuationInvestors
Founders
Product
Features
- The startup develops AI technology that accelerates molecular discovery by utilizing machine learning algorithms to analyze molecular activity for precise identification of potential drug compounds. This approach enhances the efficiency of drug compound discovery and simplifies virtual screening benchmarks for pharmaceutical companies.